Brian Mitchell

Transactional Quantitative Analyst
Full contact info

I combine strategy and analytics to solve challenging problems for clients.

Passions

Poker

Chess

Table tennis

Education

Rider University
BS, Accounting, magna cum laude

Experience

NGM Biopharmaceuticals Announces $122 Million Series A

July 17, 2024

Cooley advised NGM Biopharmaceuticals (NGM Bio), a wholly owned subsidiary of NGM Bio Holdings and a privately held biotechnology company focused on discovering and developing transformative therapeutics for patients, on its $122 million Series A financing.

Read more

Related contacts

Lauren Creel
Partner, Palo Alto
Chadwick Mills
Partner, San Francisco
Lindsy Solanki
Special Counsel, Palo Alto
Emily Iannarelli
Associate, Palo Alto
Alex Maki
Associate, Palo Alto
Jared S. Abes
Associate, Palo Alto
Eric Steiner
Paralegal Specialist, San Francisco
Brian Mitchell
Transactional Quantitative Analyst, New York
John Sellers
Partner, Palo Alto

Related Practices & Industries

Heartbeat Health Announces Series C Financing

July 9, 2024

Cooley advised Heartbeat Health, one of the top cardiovascular care companies in the US, on the close of its Series C financing led by Cressey & Company, a private investment firm focused on building leading healthcare services and information technology businesses.

Read more

Related contacts

Josh Seidenfeld
Partner, Palo Alto
John Sellers
Partner, Palo Alto
Milson Yu
Partner, Palo Alto
Arielle H. Friehling
Associate, San Francisco
Seth Holoweiko
Associate, Colorado
Elaine Huang
Associate, Palo Alto
Kelley Harrington
Associate, Palo Alto
Brian Mitchell
Transactional Quantitative Analyst, New York

Related Practices & Industries

Memberships and affiliations

Certified Public Accountant – New Jersey